The insulin-loaded microemulsion containing 10% oleic acid, 38% aqueous phase, and 50% surfactant phase with 2% DMSO as permeation enhancer showed maximum permeation flux and can be transdermally administered in the treatment of insulin-dependent diabetes mellitus with improved patient compliance. Here, INS is linked to type 1 diabetes mellitus.